European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 5.44
0.00 (0.00%)
Mar 2, 2026, 9:00 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €23.02 million as of March 2, 2026. Its market cap has decreased by -12.27% in one year.
Market Cap
23.02M
Enterprise Value
39.44M
Revenue
49.47M
Ranking
n/a
PE Ratio
19.62
Stock Price
€5.44
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 23.02M, a decrease of -73.27%. That is a compound annual growth rate of -12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 23.02M | 4.60% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 47.94B |
| argenx SE | 40.23B |
| Financière de Tubize | 9.95B |
| Onward Medical | 229.63M |
| Hyloris Pharmaceuticals | 199.92M |
| Celyad Oncology | 17.46M |
| BioSenic | 1.70M |
| Oxurion NV | 392.55K |